OP Yesterday - 04:14 AM
Artivion, a maker of cardiovascular equipment, disclosed on Monday that a cyberattack occurred on or about November 21, 2024, that disrupted its operations and temporarily took some systems offline.
In a formal filing with the SEC , the company said it had taken steps to respond to the incident, including shutting down certain systems, initiating an investigation, and engaging outside counsel, including attorneys, security specialists, and forensic experts. The filing also said the attackers encrypted files and accessed data stored on the compromised systems. The company said
it was working to safely restore its infrastructure and was evaluating potential notification obligations to affected parties. The attack affected corporate operations, order processing, and product delivery.
Most of the breach has been resolved, but the company expects additional costs that will not be covered by insurance. Artivion also warned of risks associated with delays in restoring systems, which could lead to a significant impact on the company's future operations.
While no hacker group has yet claimed responsibility for the attack, such attacks are often accompanied by the release of data if the ransom is not paid.
Artivion develops cardiovascular products, including stent grafts, surgical sealants, mechanical heart valves, and implantable tissues. The company has manufacturing facilities in the United States and Germany, and its products are available in more than 100 countries. The company is projected to have revenues of approximately $396 million in 2024.
source : https://www.sec.gov/Archives/edgar/data/...241209.htm
In a formal filing with the SEC , the company said it had taken steps to respond to the incident, including shutting down certain systems, initiating an investigation, and engaging outside counsel, including attorneys, security specialists, and forensic experts. The filing also said the attackers encrypted files and accessed data stored on the compromised systems. The company said
it was working to safely restore its infrastructure and was evaluating potential notification obligations to affected parties. The attack affected corporate operations, order processing, and product delivery.
Most of the breach has been resolved, but the company expects additional costs that will not be covered by insurance. Artivion also warned of risks associated with delays in restoring systems, which could lead to a significant impact on the company's future operations.
While no hacker group has yet claimed responsibility for the attack, such attacks are often accompanied by the release of data if the ransom is not paid.
Artivion develops cardiovascular products, including stent grafts, surgical sealants, mechanical heart valves, and implantable tissues. The company has manufacturing facilities in the United States and Germany, and its products are available in more than 100 countries. The company is projected to have revenues of approximately $396 million in 2024.
source : https://www.sec.gov/Archives/edgar/data/...241209.htm
![[Image: eibpjgI.gif]](https://i.imgur.com/eibpjgI.gif)
![[Image: Sig.png]](https://i.ibb.co/xh4Mcd3/Sig.png)